[{"AccountsPayableCurrent_0_Q1_USD":5932000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":257424000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":201648000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":201575000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":275000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":348000.0,"AssetsFairValueDisclosure_0_Q1_USD":201648000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5475000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-6518000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":56179000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":383000.0,"InvestmentIncomeInterest_1_Q1_USD":1136000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":167000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":2959000.0,"OperatingLeaseExpense_1_Q1_USD":138000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-34101000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":147000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":63000.0,"NonoperatingIncomeExpense_1_Q1_USD":1136000.0,"LesseeOperatingLeaseDiscountRate_0_Q1_pure":0.1,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":502000.0,"RestrictedCash_0_Q1_USD":403000.0,"ProceedsFromStockPlans_1_Q1_USD":324000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":44243000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":15370000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":63000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1989000.0,"OperatingLeasePaymentsUse_1_Q1_USD":195000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4398000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":487000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":952000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":591000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":802000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":818000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":834000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":851000.0,"OperatingLeaseLiability_0_Q1_USD":3446000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":324000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1613000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":383000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-36098000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":28873000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":707000.0,"LiabilitiesCurrent_0_Q1_USD":17696000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":273756000.0,"Liabilities_0_Q1_USD":20655000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":847000.0,"NetIncomeLoss_1_Q1_USD":-34164000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.78,"CommonStockSharesOutstanding_0_Q1_shares":43996753.0,"CommonStockSharesIssued_0_Q1_shares":44088390.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":55776000.0,"AssetsCurrent_0_Q1_USD":267860000.0,"Assets_0_Q1_USD":273756000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4177009.0,"AdditionalPaidInCapital_0_Q1_USD":612552000.0,"CommonStockValue_0_Q1_USD":44000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-6673000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10436000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3504000.0,"ShareBasedCompensation_1_Q1_USD":5475000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":12796000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":22504000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ProfitLoss_1_Q1_USD":-34164000.0,"OperatingIncomeLoss_1_Q1_USD":-35300000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":11277000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":44049843.0,"StockholdersEquity_0_Q1_USD":253101000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-359495000.0,"OperatingExpenses_1_Q1_USD":35300000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":null,"Ticker":"RYTM","CIK":"1649904","name":"RHYTHM PHARMACEUTICALS, INC.","OfficialName":"Rhythm Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"415723429.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200504"}]